MGA Clinical Education Series · 9 min read
A patient walks into your clinic with an itchy, red, scaly rash on the elbows and knees. Another presents with widespread, poorly-defined pale patches on the trunk after using an OTC cream. A third has a raised, silvery-scaled plaque on the extensor surface of the forearm that has been there for months. Three patients, three different conditions — but from a cursory clinical glance, they can look confusingly similar.
Misdiagnosis between eczema (atopic dermatitis), psoriasis, and tinea (fungal rash) is remarkably common in general practice globally — and even more common in India, where steroid-modified tinea has become an epidemic masquerading as other conditions. This guide walks through the key clinical differentiators that help a general physician reach the correct diagnosis quickly in the OPD, with a side-by-side comparison table and a simple decision framework that works in real-world practice.
⚡ Quick Differential Summary
Eczema: Itch comes first → redness follows from scratching. Flexural surfaces (elbows, knees, neck). Lichenified skin, poor demarcation.
Psoriasis: Well-demarcated plaques with silvery scale. Extensor surfaces (elbows, knees, shins, scalp). Systemic features possible (nail pitting, arthritis).
Fungal (Tinea): Ring-shaped or atypical borders. Active border + central clearing (or pale centre if steroid-modified). KOH positive. Localized itch at border.
Red flag: History of OTC cream use → suspect steroid-modified tinea mimicking eczema or psoriasis.
🔀 Why These Three Conditions Get Confused So Often
All three conditions produce erythema (redness), scaling, and pruritus (itching). All three can present in a localized patch or become widespread. All three are chronic. To an untrained eye — and occasionally even to a trained one — they appear nearly identical.
The reason for confusion is structural: eczema and psoriasis are conditions of altered cutaneous immunity and barrier function; tinea is an infection. These arise from entirely different mechanisms — but the endpoint (inflammation, scaling, itch) is visually similar. Add to this the reality that in India, a fungal infection that has been treated with steroids (steroid-modified tinea) can look exactly like eczema or psoriasis, and misdiagnosis becomes not just common but expected.
A machine-learning study published in Frontiers in Medicine (Ding et al., 2025, doi: 10.3389/fmed.2025.1667794) found that even with routine clinical data, eczema and psoriasis could not be distinguished with complete accuracy — illustrating that this differential is nuanced even with systematic approaches. The addition of a third condition (tinea) adds complexity but also opportunity: because tinea is fundamentally an infection, it responds to antifungals and has specific diagnostic tests (KOH), whereas eczema and psoriasis do not.
🧴 Eczema (Atopic Dermatitis): Key Clinical Features
Classic phrase: “The itch that rashes” — not “the rash that itches.” This is the most clinically useful way to remember eczema’s hallmark. The itching comes first, often severe; scratching produces the visible rash and inflammation.
🔍 Eczema: Clinical Checklist
Distribution: Flexural surfaces — antecubital fossa (crook of elbow), popliteal fossa (back of knee), neck, face, hands. In adults, often limited to hands or face. Children present with more widespread involvement.
Appearance: Poorly demarcated (ill-defined borders). Lichenification (thickened, leather-like skin from chronic scratching). Erosions from scratching. Acute phase: vesicles and weeping. Chronic phase: dry, cracked, thickened skin.
Itch character: Intense, often worse at night. Described as “maddening.” Scratch-itch cycle is central to perpetuation — the more you scratch, the more inflamed it becomes, the more it itches.
Associated features: History of atopy (allergic asthma, allergic rhinitis, food allergy). Dry skin (xerosis) as baseline. May respond temporarily to steroids but relapses when stopped — if steroids alone are used without addressing barrier dysfunction.
Response pattern: Responds well to emollients (moisturisers) + topical corticosteroids for acute flares + long-term barrier repair. Once correctly identified, it is predictable and manageable.
🏛️ Psoriasis: Key Clinical Features
Classic phrase: “The rash that (sometimes) itches” — the plaque is present from the outset; itch is secondary and variable. An autoimmune condition in which the immune system attacks skin cells, causing rapid epidermal turnover.
🔍 Psoriasis: Clinical Checklist
Distribution: Extensor surfaces — elbows, knees, shins, forearms, scalp, lower back, nails, ears. Psoriasis “loves bones” (bony prominences). Face and flexural areas are usually spared, which helps differentiate from eczema.
Appearance: Well-demarcated plaques with a silvery or mica-like scale. The scale is often thick and adherent — when scraped off, pinpoint bleeding occurs (Auspitz sign). Sharp borders are characteristic. Lesions are thicker and more planar than eczema.
Itch character: Variable — some patients report no itch at all; others report burning or soreness rather than intense itch. The plaque is visible and persistent; it does not improve simply from avoiding scratching.
Associated features: Family history (positive in ~30% of patients). Nail involvement is common — pitting (tiny holes), onycholysis (separation from nail bed), subungual hyperkeratosis. Some patients have psoriatic arthritis (joint inflammation) — a key systemic clue not present in eczema or tinea.
Response pattern: Chronic, cyclical (periods of remission and flare). Responds to topical steroids and vitamin-D analogues. Systemic triggers include stress, infections, certain medications (beta-blockers, lithium). Unlike tinea, psoriasis is never eradicated — it is managed long-term.
🍄 Fungal Rash (Tinea): Key Clinical Features
Classic phrase: “Ring-shaped with a moving border.” The active border (periphery) is the site of active fungal invasion; the centre may clear (classic ringworm) or remain pale and poorly-defined if the patient has applied a steroid (steroid-modified tinea).
🔍 Fungal Rash (Tinea Corporis/Cruris/Faciei): Clinical Checklist
Distribution: Any site — trunk, flexural and extensor surfaces equally affected. Tinea corporis: trunk and limbs. Tinea cruris: inguinal fold, pubic area, inner thigh (moist areas). Tinea faciei: face (less common but increasing).
Appearance: Classic: annular (ring-shaped) lesions with an active scaly border and central clearing. Atypical (if steroid use): pale, ill-defined borders, loss of central clearing, diffuse erythema, bizarre geographic shapes, pustular borders. Border is often the most inflamed area.
Itch character: Localized, stinging itch strictly confined to the active border — patients often report itch at the edges only. Less intense than eczema, but more specific.
Associated features: History of OTC cream use (pharmacy recommendation in 78% of cases, per IJDVL). Temporary relief from steroid cream followed by recurrence. Contagiousness — may spread to other body sites or to contacts. In India: increasing resistance to standard antifungals.
Response pattern: Antifungal-responsive. KOH preparation from lesion scraping shows branching hyphae. Curable — unlike eczema and psoriasis, tinea can be completely cleared with appropriate antifungal therapy if steroids are discontinued and the infection has not been modified by prolonged steroid use.
📊 Side-by-Side Comparison Table
| Feature | Eczema | Psoriasis | Fungal (Tinea) |
|---|---|---|---|
| Primary site | Flexural (elbows, knees, neck, face) | Extensor (elbows, knees, shins, scalp) | Any — often moist areas (groin, axillae) |
| Border | Poorly demarcated, indistinct | Sharp, well-demarcated | Active border, often ring-shaped (or atypical if steroid-modified) |
| Scale | Fine, lichenified (thickened, leathery) | Thick, silvery, mica-like, adherent | Dry, powdery, at border mainly |
| Central clearing | No | No | Yes (classic) — absent if steroid-modified |
| Itch intensity | Severe, primary complaint | Variable (some none), burning/soreness common | Mild to moderate, localized to border |
| Nail changes | Rare, non-specific | Pitting (tiny holes), onycholysis, subungual hyperkeratosis — DIAGNOSTIC if present | Onychomycosis if nails involved (thickening, discolouration, crumbling) |
| Systemic signs | Allergy history (asthma, hay fever) | Arthritis (psoriatic arthritis), uveitis, family history | None — localized infection |
| KOH test | Negative | Negative | POSITIVE — branching hyphae visible |
| Response to steroids alone | Temporary relief, relapses without barrier repair | Partial control, chronic management | Paradoxical worsening — steroids suppress immunity, fungus spreads |
| Prognosis | Chronic, manageable with emollients + steroids | Chronic, cyclical, requires long-term management | Curable with appropriate antifungals (if steroids stopped) |
⚠️ The Steroid-Modified Tinea Trap: When Fungal Mimics Eczema or Psoriasis
Here is where the differential becomes clinically dangerous: an undiagnosed fungal infection that has been treated with an OTC corticosteroid can look exactly like eczema or psoriasis. This is the “steroid-modified tinea trap” — and it is epidemic in India. For detailed clinical recognition of this presentation, see our full article on steroid-modified tinea in India.
🚨 Red Flag Pattern
If you see this: A patient with a widespread, poorly-defined, pale rash that initially responded well to an OTC cream (pharmacy-recommended), felt better for a week, then returned larger, more widespread, and now harder to define — suspect steroid-modified tinea, not eczema or psoriasis.
What to do: Ask directly: “Did you use a cream from a pharmacist? What was the brand?” (Common brands in India: Panderm Plus, Quadriderm, Fourderm, Betnovate-C, Tenovate-M). If yes, suspect fungal. Do a KOH scraping from the active border immediately. Stop the cream. Start antifungal (not steroid).
The IJDVL clinico-epidemiological study (Dutta, Rasul & Boro, 2017) documented that 78% of tinea incognito cases were initiated by a pharmacist recommending a combination cream. Zero cases in that study originated from a dermatologist’s prescription — illustrating that proper clinical recognition is the intervention that stops the cascade.
🎯 A Simple Decision Framework for the OPD
Use this framework when a patient presents with an itchy, scaly rash and you need to decide quickly:
Ask about OTC cream use
If yes → suspect fungal. Do KOH immediately. Stop the cream.
Observe distribution — flexural vs extensor
Flexural (elbows, knees, neck) → likely eczema. Extensor (elbows, shins, scalp) + silvery scale → psoriasis. Both + ring shape → fungal. Atypical distribution + OTC cream history → steroid-modified tinea.
Check for nail involvement
Pitting + nail changes = psoriasis (very strong signal). Onycholysis + thickened yellow nails = fungal. Normal nails = eczema likely.
When uncertain: Do KOH
Scratch the active border gently, mount on a glass slide with 10% KOH, examine under the microscope. Hyphae = fungal. No hyphae = eczema or psoriasis. This one test clarifies > 90% of diagnostic uncertainty and costs almost nothing.
Systemic clues
Psoriatic arthritis or uveitis = psoriasis. Atopy (asthma, hay fever) = eczema. Contacts with similar lesions = fungal (contagious).
❓ Frequently Asked Questions
Can a patient have more than one of these conditions at the same time?
Yes, though rarely. A patient with psoriasis can develop a secondary bacterial or fungal infection. A patient with eczema can also have tinea (especially in moist areas). However, this is uncommon. It is far more common for one condition to be misdiagnosed as another — especially fungal masquerading as eczema or psoriasis after steroid use.
Can eczema or psoriasis be cured?
No. Both are chronic conditions managed long-term. Eczema improves significantly with emollients and topical steroids for flares + barrier repair. Psoriasis is cyclical and requires ongoing management with topical agents, phototherapy, or systemic treatments depending on severity. Tinea, by contrast, can be cured — if properly identified and treated with antifungals before steroid use has caused permanent morphological changes.
What if my KOH test is negative but I still suspect fungal?
A single negative KOH does not rule out fungal. KOH sensitivity is ~70–80% depending on collection technique and sample quality. If clinical suspicion is high (OTC cream history, ring-shaped lesion, localized border itch), request a fungal culture or send samples for mycological examination. A culture takes longer but is more sensitive and also identifies the species — important in India where resistant strains are emerging.
Is steroid-modified tinea more common in India than elsewhere?
Yes. India has been described by the Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) as experiencing an “unprecedented epidemic” of steroid-modified dermatophytosis. Contributing factors include: (1) tropical/subtropical climate favouring fungal growth, (2) widespread OTC availability of combination steroid-antifungal-antibiotic creams, (3) high pharmacist involvement in recommending creams without medical supervision, and (4) emergence of terbinafine-resistant strains. This makes the steroid-modified tinea trap particularly relevant to Indian general practitioners.
What should I teach my patient about skin care for eczema vs psoriasis?
For eczema: Emphasise barrier repair — frequent moisturising with fragrance-free emollients (e.g. glycerin-based creams), lukewarm baths or showers, avoid harsh soaps. For psoriasis: Warn that stress, infections, and certain medications (beta-blockers, lithium) can trigger flares. Both conditions benefit from avoiding irritants and excessive scratching — but the approach is fundamentally different. For tinea: Emphasise that OTC creams (especially combination creams with steroids) will paradoxically make it worse. Proper antifungal + hygiene (loose cotton clothes, hot-water laundry, avoid sharing towels) is the correct approach.
📖 Explore the Cluster
Related Clinical Guides in This Series
→ Acne management for general physicians in India
Deepen Your Differential Diagnosis Skills
Confident differential diagnosis of common dermatological presentations — eczema, psoriasis, tinea, and their atypical variants — is a cornerstone clinical skill. MGA’s Fellowship in Dermatology equips doctors with the pattern recognition, diagnostic techniques, and decision-making frameworks needed to manage the full spectrum of presentations they will encounter in practice.
Disclaimer: This article is intended for qualified medical professionals and is for educational and informational purposes only. It does not constitute clinical advice or a diagnostic recommendation. All clinical decisions should be based on the individual patient’s presentation, local guidelines, and the treating clinician’s professional judgement. Readers should confirm uncertain diagnoses with appropriate diagnostic tests (KOH, culture, biopsy) before initiating treatment.